OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
© 2020 MJH Life Sciences™ and BioPharm International. All rights reserved.
November 04, 2020
At the 2020 Bio/Pharma Virtual Congress, experts discuss the importance of characterizing excipients to ensure quality, safety, and effective performance.
October 15, 2020
The IQ Consortium marks a decade of impactful innovation of collaboration through a network of pharmaceutical companies driving change for the bio/pharmaceutical industry.
August 02, 2020
Many antibody-drug conjugate therapies are in the pipeline; only a handful have been approved. What are the bottlenecks?
July 08, 2020
The European Commission has approved Lynparza (olaparib) for use in patients with germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer within the European Union.
July 02, 2020
RNA is easier to manipulate than DNA but challenging to deliver to the right cells.
July 01, 2020
Data and science must guide FDA in making pressure-filled COVID-19 vaccine and therapy approval decisions.
June 01, 2020
Therapies for early and late treatment and passive immunization of COVID-19 are needed and can be developed using antibodies from recovered patients.
April 14, 2020
With the acquisition, Orgenesis will combine TamirBio’s ranpirnase antiviral platform with its Bioxome technology.
April 01, 2020
As a result of the rising use and development of biological drugs, the biopharma industry is witnessing an increase in the adoption of prefilled syringes.
March 01, 2020
Contract service organizations can offer biopharma companies early insight into dangers that may hinder a drug’s later development.